Harbour Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-1,025
| Closed | -$270K | – | 280 |
|
2023
Q4 | $270K | Buy |
+1,025
| New | +$270K | 0.07% | 226 |
|
2020
Q2 | – | Sell |
-643
| Closed | -$203K | – | 194 |
|
2020
Q1 | $203K | Buy |
+643
| New | +$203K | 0.1% | 165 |
|
2019
Q3 | – | Sell |
-2,317
| Closed | -$542K | – | 201 |
|
2019
Q2 | $542K | Sell |
2,317
-2,206
| -49% | -$516K | 0.23% | 115 |
|
2019
Q1 | $1.07M | Buy |
4,523
+539
| +14% | +$127K | 0.47% | 75 |
|
2018
Q4 | $1.2M | Buy |
3,984
+537
| +16% | +$162K | 0.6% | 59 |
|
2018
Q3 | $1.22M | Buy |
3,447
+679
| +25% | +$240K | 0.49% | 66 |
|
2018
Q2 | $819K | Buy |
2,768
+1,260
| +84% | +$373K | 0.35% | 97 |
|
2018
Q1 | $413K | Buy |
1,508
+647
| +75% | +$177K | 0.18% | 149 |
|
2017
Q4 | $274K | Hold |
861
| – | – | 0.11% | 202 |
|
2017
Q3 | $270K | Hold |
861
| – | – | 0.12% | 200 |
|
2017
Q2 | $234K | Sell |
861
-400
| -32% | -$109K | 0.12% | 203 |
|
2017
Q1 | $345K | Hold |
1,261
| – | – | 0.16% | 164 |
|
2016
Q4 | $358K | Buy |
1,261
+670
| +113% | +$190K | 0.26% | 117 |
|
2016
Q3 | $185K | Buy |
+591
| New | +$185K | 0.12% | 189 |
|
2016
Q2 | – | Sell |
-778
| Closed | -$203K | – | 227 |
|
2016
Q1 | $203K | Hold |
778
| – | – | 0.12% | 202 |
|
2015
Q4 | $238K | Hold |
778
| – | – | 0.13% | 197 |
|
2015
Q3 | $227K | Hold |
778
| – | – | 0.16% | 166 |
|
2015
Q2 | $314K | Hold |
778
| – | – | 0.2% | 145 |
|
2015
Q1 | $329K | Sell |
778
-801
| -51% | -$339K | 0.23% | 139 |
|
2014
Q4 | $536K | Buy |
+1,579
| New | +$536K | 0.38% | 96 |
|